SUMMARY Plasma levels of 1,25 dihydroxy-vitamin D (1,25-(OH)2-D) were low in 3 children with hypophosphataemic vitamin D-resistant rickets (HVDRR) during childhood, but increased after very large doses (0 * 5 to 2 ,g/kg per day) of 1 ao-hydroxy-vitamin D (1 ac-OH-D3). This treatment has two advantages. Firstly, hypercalcaemia is easily controlled by reducing the dose of oc-OH-D3 because of its short half-life. Secondly, the administration of 1 ac-OH-D3 to patients with HVDRR can enhance the tubular reabsorption of phosphate, and this seems desirable in treating HVDRR. 
Materials and methods
Three patients who had shown the characteristic clinical and biochemical features of HVDRR were studied. Their ages, physical findings, and clinical features are listed in Table 1 . Each patient was a sporadic case. The plasma levels of 1,25-(OH)2-D were measured by the competitive protein-binding assay which has been reported.3-4 10 normal children (4 boys and 6 girls), aged between 2 and 15 years, were studied as controls. All plasma samples were obtained early in the morning after overnight fasting during the autumn. Tubular reabsorption of phosphate was estimated by the 24-hour clearance rate and the renal threshold phosphate concentration (TmP/GFR) was measured according to the method of Bijvoet.5
Results Plasma 1,25-(OH)2-D concentration. The mean plasma level of 1,25-(OH)2-D in controls was 72 + 17 9 (means ± SD) pg/ml. In Case 1 this increased from 11-2 to 96 0 pg/ml 3 months after 
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